KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Teradyne (TER) Research & Development (2016 - 2025)

Teradyne's Research & Development history spans 17 years, with the latest figure at $143.3 million for Q4 2025.

  • For Q4 2025, Research & Development rose 11.59% year-over-year to $143.3 million; the TTM value through Dec 2025 reached $504.6 million, up 9.49%, while the annual FY2025 figure was $504.6 million, 9.49% up from the prior year.
  • Research & Development reached $143.3 million in Q4 2025 per TER's latest filing, up from $124.8 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $143.3 million in Q4 2025 to a low of $100.4 million in Q2 2021.
  • Average Research & Development over 5 years is $112.6 million, with a median of $110.0 million recorded in 2021.
  • Peak YoY movement for Research & Development: fell 6.54% in 2023, then grew 25.61% in 2024.
  • A 5-year view of Research & Development shows it stood at $110.0 million in 2021, then fell by 1.05% to $108.8 million in 2022, then dropped by 6.07% to $102.2 million in 2023, then increased by 25.61% to $128.4 million in 2024, then rose by 11.59% to $143.3 million in 2025.
  • Per Business Quant, the three most recent readings for TER's Research & Development are $143.3 million (Q4 2025), $124.8 million (Q3 2025), and $118.4 million (Q2 2025).